rood blauwe elepsis logo Belegger.nl

Sopheon Terug naar discussie overzicht

Sopheon maart 2022

16 Posts
| Omlaag ↓
  1. Bertus S 24 maart 2022 08:03
    Results Statement for the Year Ended 31 December 2021

    Sopheon plc, the international provider of software and services for Enterprise Innovation Management solutions, is pleased to announce its results for the year ended 31 December 2021, together with an outlook for the current year.

    Financial Highlights:

    Revenue of $34.4m, ahead of market expectations in the face of continued COVID challenges, whilst embedding the SaaS transition (2020: $30.0m)
    ARR1 rose from $18.0m at the start of 2021 to $20.7m at the end of the year
    Full year 2022 revenue visibility2 stands at $25.1m (last year at this time: $24.5m)
    Gross retention at 95% (2020: 91.5%)
    Adjusted EBITDA3 of $6.2m (2020: $5.9m) also ahead of market expectations
    Profit before tax of $1.2m (2020: $1.7m) affected by higher amortization and share based payments
    Net cash of $24.2m (2020: $21.7m) and the Group has no debt
    Dividend to be maintained at 3.25p per share (2020: 3.25p)

    Operational Highlights

    10 new customer wins of which 9 were SaaS, driving rising quality of earnings and demonstrating the successful shift to a SaaS model. Looking forward, the license pipeline for new customers approaching 90% SaaS. Another six existing clients (2020: 4) were converted to SaaS as part of the Group’s SaaS Uplift program.
    Acceleration of product investment resulted in a higher delivery pace for enterprise Accolade releases. In parallel, investment in cloud-native solutions, with a first application targeted at expanding the Accolade user community. Initial application to launch mid-2022.
    We stepped up marketing programs and investment significantly in 2021 to extend market reach, prospect engagement and ultimately lead generation. This expanded go-to-market strategy is geared to increase new customer acquisition, reducing reliance on large customers who require particular capabilities, and to address a broader target market in order to improve scalability and predictability.
    The acquisition of ROI Blueprints business added deep project management capability eliminating the need for customer purchase and integration of third-party tools in that area.
    Greg Coticchia was appointed CEO during the year, also introducing new leadership in sales, marketing and product areas.
    Andy Michuda, Chairman, commented: “2021 was a year of new leadership, new processes, new programs, and extensive organizational change, together with solid financial outcomes and an initial acquisition. With the initiation of change behind us and the organizational structure and leadership in place, 2022 is very much focused on accelerating and operationalizing the effectiveness of this change. I believe that the future is bright for Sopheon and for Sopheon shareholders.”

    For further information contact:

    Andy Michuda (Chairman)
    Arif Karimjee (CFO) Sopheon plc + 44 (0) 1276 919 560
    Carl Holmes/ Edward Whiley (Corporate Finance)
    Alice Lane/Sunila de Silva (ECM) finnCap Ltd + 44 (0) 20 7220 0500

    www.sopheon.com/financial-releases/re...

    Bertus S.
  2. Tritace 24 maart 2022 08:45
    Thx Bertus!
    Weinig verrassingen. 2021 het jaar vd verandering
    2022 jaar vd versnelling. We gaan het zien
    " believe that the future is bright for Sopheon and for Sopheon shareholders.”"
  3. abc123xyz987 24 maart 2022 10:09
    Inderdaad weinig verassingen. Wel een hoop american-style bla bla tekst.
    De omzetgroei tussen jan 2021 en nu valt mij tegen. Kan natuurlijk door SAAS komen maar had ik hoger ingeschat nu.
    De nieuwe marketing en sales mensen moeten aan de bak!

    Groet ABC
  4. Gartje 24 maart 2022 12:12
    Volgens mij waren deze cijfers al bekend, Outlook is waar we ons op moeten richten, en gezien het aantal van aandelen wat in vaste handen is kan die laatste zin niet zo maar gezegd worden. Het vertrouwen dat het er goed uitziet voor de aandeelhouders is voor nu even waar ik vertrouwen uit kan halen. Dus rustig afwachten en hopen op een mooi 2022!,
  5. Tritace 25 maart 2022 22:55
    Vond ik nog een interessant deel in de update en een mogelijkheid om de omzet op te krikken

    We are also moving towards a multi-product future, expanding beyond our enterprise Accolade solution. We have ambitious plans in the product investment area which will take patience and time. Our goals here are to:

    - Continue to advance our flagship Accolade enterprise solution and maintain our market leadership. During 2021, three new versions were released, and we plan an ongoing pace of four per year going forward.

    - Introduce new cloud-based applications providing value to individual and workgroup users in the corporate ecosystem, alongside Accolade’s enterprise value proposition. Initial market introduction of the first application is planned for mid-2022. These applications are intended to be stand-alone solutions that solve individual productivity needs in addition to creating future upsell opportunities for Accolade
  6. Tritace 28 maart 2022 08:33
    quote:

    abc123xyz987 schreef op 24 maart 2022 10:09:

    Inderdaad weinig verassingen. Wel een hoop american-style bla bla tekst.
    De omzetgroei tussen jan 2021 en nu valt mij tegen. Kan natuurlijk door SAAS komen maar had ik hoger ingeschat nu.
    De nieuwe marketing en sales mensen moeten aan de bak!

    Groet ABC
    Vraagje: welke omzetgroei zou jij voor dit jaar "acceptabel" vinden?
  7. Tritace 29 maart 2022 16:15
    Sopheon and The AIM Institute Partner to Redefine Product Innovation Process
    Combining “Fuzzy Front End” of Ideas with New Product Development Phase May Dramatically Boost New Product Success Rates

    MINNEAPOLIS – March 29, 2022 – Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, and The AIM Institute, the global leader in B2B voice-of-the-customer (VOC) training and software, today announced a partnership that will ensure customer insights become the cornerstone for a company’s innovation processes. With AIM’s Blueprinter® software automatically flowing into Sopheon’s Accolade® innovation management software, companies will be able to manage innovation and new product development programs based on the customer’s stated business goals.

    www.sopheon.com/news-releases/sopheon...
  8. abc123xyz987 29 maart 2022 23:38
    quote:

    Tritace schreef op 28 maart 2022 08:33:

    [...]

    Vraagje: welke omzetgroei zou jij voor dit jaar "acceptabel" vinden?
    Hoi Tritache,
    Ik ben mijn spreadsheet aan het bijwerken n.a.v. de nieuwe cijfers. Kom zsm terug op je vraag.
    Groet ABC.
  9. abc123xyz987 29 maart 2022 23:41
    quote:

    Tritace schreef op 29 maart 2022 16:15:

    Sopheon and The AIM Institute Partner to Redefine Product Innovation Process
    Combining “Fuzzy Front End” of Ideas with New Product Development Phase May Dramatically Boost New Product Success Rates

    www.sopheon.com/news-releases/sopheon...
    Mooi bericht!
  10. Tritace 2 april 2022 17:48
    quote:

    abc123xyz987 schreef op 29 maart 2022 23:38:

    [...]

    Hoi Tritache,
    Ik ben mijn spreadsheet aan het bijwerken n.a.v. de nieuwe cijfers. Kom zsm terug op je vraag.
    Groet ABC.
    Fijn! Thx alvast.
  11. abc123xyz987 13 april 2022 21:38
    quote:

    Tritace schreef op 28 maart 2022 08:33:

    [...]

    Vraagje: welke omzetgroei zou jij voor dit jaar "acceptabel" vinden?
    ongeveer zo.
    Groet ABC
  12. Tritace 1 mei 2022 22:24
    Bedankt ABC voor je werk aan de spreadsheet. Lijkt er toch op dat 2022 nog weer een "overgangsjaar" (naar SaaS, uitbreiding portfolio etc) gaat worden. Hoop zelf toch op iets meer dan de 37,5. Mogelijk dat update in juni een eerste zal geven.
16 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 6.997
AB InBev 2 5.479
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.112
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.445
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.622
Aedifica 3 900
Aegon 3.258 322.599
AFC Ajax 537 7.084
Affimed NV 2 6.287
ageas 5.844 109.883
Agfa-Gevaert 14 2.046
Ahold 3.538 74.287
Air France - KLM 1.025 34.972
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.017
Alfen 16 24.222
Allfunds Group 4 1.467
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 403
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.806
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.834 242.585
AMG 971 132.996
AMS 3 73
Amsterdam Commodities 305 6.685
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 481
Antonov 22.632 153.605
Aperam 92 14.885
Apollo Alternative Assets 1 17
Apple 5 375
Arcadis 252 8.731
Arcelor Mittal 2.033 320.441
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.279
Aroundtown SA 1 219
Arrowhead Research 5 9.715
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.060
ASML 1.766 105.281
ASR Nederland 21 4.450
ATAI Life Sciences 1 7
Atenor Group 1 465
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.579
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.383